Aquablation therapy for benign prostate enlargement in Canada
Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).
This study looks at how well Aquablation therapy works for men with benign prostate enlargement in Canada over three years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Can-Am HIFU Inc. Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT05169892 on ClinicalTrials.gov |
What this trial studies
This study documents the clinical outcomes of Aquablation therapy for patients with benign prostatic hyperplasia (BPH) in a Canadian cohort. Male subjects aged 18 and older who are candidates for Aquablation will be followed for three years as part of standard care. The study aims to gather data on the effectiveness and safety of this treatment approach in managing BPH.
Who should consider this trial
Good fit: Ideal candidates for this study are male patients aged 18 and older diagnosed with benign prostatic hyperplasia who are suitable for Aquablation therapy.
Not a fit: Patients with health conditions that make them unsuitable for the study or those unable to comply with the study protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness of Aquablation therapy, potentially improving treatment options for patients with BPH.
How similar studies have performed: While this study focuses on a specific cohort, similar approaches using Aquablation therapy have shown promise in other settings, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary diagnosis of Benign Prostate Hypertrophy (BPH) * Male subjects of ≥ 18 years of age * Candidate for Aquablation therapy as per clinical decision of Investigator * Willing and able to accurately complete questionnaires * Willing and able to provide signed and dated informed consent Exclusion Criteria: * Characteristics indicating a poor compliance with study protocol requirements. * Disease or other health condition that is not suitable for this study. * Unable or unwilling to provide signed informed consent.
Where this trial is running
Toronto, Ontario
- Dean Elterman — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Study coordinator: Dean Elterman
- Email: dean.elterman@uhn.ca
- Phone: 4166035800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.